Avenzo Therapeutics, a well-funded biotech that has in-licensed treatment candidates from Chinese drug developers, has forged its third deal since reassembling much of the Turning Point Therapeutics crew.
Athena Countouriotis' San Diego biotech is tapping ...
↧
